David C Grammer

Recommended Articles

• New Multiple Sclerosis Treatment, Ocrevus, Slows Down Disease Progression

  In 2017, the United States Food and Drug Administration (USFDA) approved the drug – Ocrevus (ocrelizumab) – as a treatment for both relapsing and progressive forms of multiple sclerosis. ...

• What is Bedtime Procrastination?

  When we hear the word “procrastination,” most people think of work. Procrastination is not something we automatically associate with bedtime or sleep. However, a new type of procrastination has been identified, and it particularly affects our behavior in the bedroom. With the influx of...

• Where Does Dengue Fever Commonly Occur?

  The vector responsible for spreading dengue feverThe mosquito Aedes Aegypti is one of the most important insect vectors in the world. Dengue fever has garnered a lot of attention over the years, and is especially problematic in affected countries.Areas most susceptible to dengue feverYou can see...

• What Causes Lower Back Pain?

  Basically anyone can experience lower back pain but studies have shown that adults of age 30 to 60 years tend to have a higher chance of experiencing back pain. Nevertheless, no one is safe from lower back pain.Lower back pain can be caused by a variety of problems with any parts of the complex,...

• New Genetic Engineering May Help Diabetes Patients with Obesity

  CRISPR genetic engineering has many applications in the medical field and has revolutionized the world of genetic engineering in the last few years because it allows for very specific alteration in the DNA of human, plants and lower animal forms much faster than was previously possible.What is...

• Antidepressants May Pose a Risk for Alzheimer's Patients

  Research shows that patients newly diagnosed with Alzheimer's disease who recently began using antidepressents are at a higher risk for head injuries and traumatic brain injuries. Heidi Taipale and colleagues from the University of Eastern Finland wrote that for older people who use...